Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 83

Results For "subsidiary"

870 News Found

Abbott launch room-temperature carbetocin in India for Postpartum Haemorrhage
News | September 01, 2021

Abbott launch room-temperature carbetocin in India for Postpartum Haemorrhage

PPH is associated with almost 20 per cent of maternal mortality in India


Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab
Digitisation | September 01, 2021

Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab

The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise


DCGI approves Enzene biosimilar Denosumab for Osteoporosis
Drug Approval | August 28, 2021

DCGI approves Enzene biosimilar Denosumab for Osteoporosis

This is Enzene Biosciences third biosimilar to be approved


Max Healthcare to set up a 500-bed capacity hospital in Delhi
Healthcare | August 28, 2021

Max Healthcare to set up a 500-bed capacity hospital in Delhi

This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024


Japan approves AstraZeneca’s Forxiga for chronic kidney disease
Drug Approval | August 28, 2021

Japan approves AstraZeneca’s Forxiga for chronic kidney disease

Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options


Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
Drug Approval | August 26, 2021

Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin

The company to receive upfront and milestone payments, in addition to royalties


Medtronic partners with ASAP, Kerala for Internship
News | August 25, 2021

Medtronic partners with ASAP, Kerala for Internship

Goal of providing 12-month internship opportunities for qualified students


Carbogen Amcis AG signs co-investment agreement
Biotech | August 25, 2021

Carbogen Amcis AG signs co-investment agreement

The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound


Lupin launches Luforbec to treat asthma & COPD in UK
News | August 24, 2021

Lupin launches Luforbec to treat asthma & COPD in UK

It is the first branded generic alternative to Fostair 100/6 pMDI


Aurobindo Pharma calls off its acquisition of Cronus Pharma
News | August 21, 2021

Aurobindo Pharma calls off its acquisition of Cronus Pharma

The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market